Restrictive Lung Disease

What is Restrictive Lung Disease?

If you have recently been diagnosed, or are extensively researching a lung disease, you may have come across the terms obstructive and restrictive lung disease. Most pulmonologists classify lung diseases as either obstructive or restrictive. While this may seem like a relatively simple way of keeping track of diseases, there are several key differences between each classification. To better understand your lung disease, let’s take a closer look at both obstructive and restrictive lung disease types.

Restrictive Lung Diseases

People with a restrictive lung disease have a difficult time filling their lungs with air because their lungs are restricted from fully expanding. Most of the time, restrictive lung diseases occur when delicate lung tissue stiffens. This sometimes occurs due to excessive stiffness in the chest wall, weak muscles or damaged nerves. Restrictive lung diseases include, but are not limited to:

Obstructive Lung Diseases

Obstructive lung diseases include conditions that make it hard to exhale all the air in the lungs. Lung damage, or the narrowing of pulmonary airways causes an inability to fully inhale and exhale, leaving a large amount of uncirculated air in the lungs. Some of the most common conditions related to obstructive lung diseases are:

Obstructive lung disease makes it harder to breathe, especially during increased activity or exertion. As the rate of breathing increases, there is less time to completely exhale before the next inhalation. This makes obstructive lung disease different from restrictive forms of the disease.

Both restrictive and obstructive lung diseases are measured using a pulmonary function test. These tests gauge lung function and overall capacity. Lung diseases can cause shortness of breath, severe coughing and chest pain.

Treating Restrictive Lung Disease

Treatment for restrictive lung disease is commonly limited to prescription drugs and supplemental oxygen. This strategy treats symptoms, but not the disease itself. This has lead sufferers to look beyond common practices to alternative treatment options. These options include homeopathic approaches like the integration of herbs and supplements into your diet to help increase lung function. Increasingly, people have been looking to pulmonary rehabilitation classes and regular exercise routines to help combat their weakening lungs. On the medical front, an innovative treatment option called cellular therapy allows patients to take their healthcare into their own hands.

Cells are the body’s natural healing mechanism. When you get a cut on your finger or suffer from a debilitating lung condition, cells travel throughout the body to target the damaged tissue and promote healing. For a simple cut, that means a couple days of scabbing and maybe a little bleeding, but eventually your skin looks like new again. Unfortunately, the same is not the case for chronic progressive disease. Cells don’t work as quickly to start the healing process of the tissue as the disease does in destroying it. Cellular therapy involves transferring cells from one part of the body to another, focusing the healing ability of the cells in a much more rapid and concentrated manner.

Lung disease doesn’t have to restrict your quality of life. If you or a loved one is interested in cellular therapy for lung disease, contact us at the Lung Institute to learn more or call (800) 729-3065 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.